Mesothelioma News Asbestos Updates Cancer News Mesothelioma Info
 

Contact Us: 1-800-523-0031
  Links:

LATEST NEWS AND UPDATES

  06/30/09  -   Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
Source: Peregrine Pharmaceuticals, Inc.

Completion of Phase I Paves Way for Expanding Bavituximab Cancer Program. Inclusion of Patients with Diverse Advanced Cancers Along with Promising Interim Phase II Data Suggest Bavituximab Could Have Broad Anti-Cancer Utility. Read More...

  03/26/09  -   New tool in the radiography approach will assist in earlier detection of asbestos-related diseases
Source: Karmanos Cancer Institute

Michael Harbut, M.D., MPH, co-director of the National Center for Vermiculite and Asbestos-Related Cancers (NCVAC) at the Barbara Ann Karmanos Cancer Institute in Detroit, MI, and chief of the Center for Occupational and Environmental Medicine Wayne State University, announced the use of a new technology to aid in the diagnosis of asbestos-related lung disease. Read More...

  03/02/09  -   Morphotek, Inc. Announces Initiation of MORAb-009 Phase II Study in First-Line Treatment of Mesothelioma
Source: Morphotek, Inc.

The study will evaluate MORAb-009, plus the chemotherapy drugs pemetrexed and cisplatinum, as a first-line treatment for patients with mesothelioma. Read More...


LATEST NEWS AND UPDATES ARCHIVES

2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002

 
HOME
LETTERS FROM OUR CLIENTS
TREATMENT OPTIONS
LEGAL RIGHTS
ASBESTOS Q & A
MESOTHELIOMA Q & A
TRADES AT RISK
DOCTORS & CANCER CENTERS
LATEST NEWS & UPDATES
CIGARETTES & ASBESTOS
CLINICAL TRIALS Q & A
CONTACT US


Copyright 2004   Blumenthal & Gruber, LLP   Post Office Box 7071, Dallas, Texas 75209-0071  

Our goal is to keep information on this website accurate and up-to-date. However, it is very important that before you act on any of the information provided here that you first seek the advice of an attorney (for a legal matter) or medical professional (for a health-related matter).

We have provided links to other websites in the hope that they will be helpful in your search for information. Please understand that Blumenthal & Gruber, LLP is not associated with these websites, we cannot vouch for the accuracy of any of the information contained in such websites, and their inclusion within this site does not, either expressly or impliedly, constitute an endorsement of the websites by Blumenthal & Gruber, LLP.